Marin M.
- Country
- Bulgaria
- Department
- NA
Research Overview
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Phase 3 Trial Comparing Efficacy, Safety, and Immunogenicity of Aflibercept (RBS-001) Versus Aflibercept in Neovascular Age-Related Macular Degeneration
- Evaluation of Tozorakimab Efficacy and Safety in Chronic Obstructive Pulmonary Disease with Exacerbation History: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 114 of 431 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in chronic obstructive pulmonary disease (COPD) treatment and management, with particular focus on innovative therapeutic combinations for respiratory conditions.
- Advanced inhaler therapies
- Bronchodilator combinations
- Cardiopulmonary outcomes
The research explores the effectiveness of triple therapy combinations in managing respiratory conditions and improving patient outcomes.
Ophthalmology
The investigator conducts research in neovascular age-related macular degeneration (nAMD), focusing on innovative therapeutic approaches for retinal disorders.
- Retinal disease management
- Visual acuity assessment
- Novel therapeutic agents
Their work encompasses comparative studies of treatments for macular degeneration, evaluating therapeutic efficacy and patient tolerance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.